In order to ascribe a mechanistic role to PTEN expression in determining functional response to MEK or mTOR inhibition, we silenced PTEN expression by shRNA in the PTEN-competent melanoma cell line M14 (clone M14/shPTEN, Figure S2C insert) and overexpressed a functional PTEN in the PTEN-loss melanoma cell line WM115 (clone WM/PTEN, Figure S2D insert). This evidence concerns the gene MTOR and melanoma.